MFN1 and melanoma: Mfn1 silencing did not affect the sensitivity of melanoma cells to the drug, since similar half-maximal inhibitory concentrations (IC50) were found for cells transfected with shMfn1 (69 ± 4 μM) or shScr (66 ± 2 μM) (Supplementary Fig. S1 online).